Log In
Print this Print this

Breast Cancer Index (BCI)

Also known as: formerly Theros Breast Cancer Index

  Manage Alerts
Collapse Summary General Information
Company bioMerieux S.A.
DescriptionRisk assessment assay that uses a combination of Theros H/I (HOXB13:IL17BR) and Theros MGI (Molecular Grade Index)
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict risk of disease recurrence in estrogen receptor-positive, lymph node-negative breast cancer patients
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today